Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. - Wikidata - awgldk - TriplyDB

Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

http://www.wikidata.org/entity/Q51838864

about

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals Endocrine causes of nonalcoholic fatty liver disease Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.Steatosis and steatohepatitis: complex disorders.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods Pattern of liver function tests in morbidly obese Saudi patients undergoing bariatric surgery Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity.Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea Treating nonalcoholic fatty liver disease.Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients.Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases.Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound.Hepatic fatty acid trafficking: multiple forks in the road Acylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats.Insulin sensitizers for the treatment of non-alcoholic fatty liver disease Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis.Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity.Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System.Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study.Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.Nonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound Evaluation Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?

P2860

Q22299426-33DA5A8C-85DD-473A-A447-0BC34D290447 Q26780254-E1517CC2-F000-44D3-B98E-5D559F40C01B Q26800894-16018E0E-9FD6-4EE9-971A-AB81C597FCC5 Q26852019-1A01F0E6-5166-4901-B2E5-FDC69899202A Q31153508-6CF14A13-08BC-425E-8C0E-5B158D6615D7 Q33263279-D261058A-6D26-48CA-B8AF-D4D283FF86A7 Q33907632-B2A03E38-B808-4C23-A75D-2A0B95DE8C81 Q34205386-10B3F51E-074F-45E1-AF37-8D45752A22C6 Q34746071-71304D99-2B11-4B0E-8FF5-2CCF95B5AB92 Q35098356-2C5AE2B8-7B0B-46CE-9C83-890A53C012E7 Q35233535-58927DC1-1A5A-40D7-BA7A-5A66EA6159B1 Q35553828-856F82A6-252C-4229-B5F2-609199A9DB02 Q35668934-5A37457D-2A2E-45BA-BAC6-6C19029D7300 Q35835264-07B00C08-EEFF-4AC7-87F8-4FC2CBB33355 Q36962239-687B8EE1-477F-4661-AC17-086F0DD1DCBC Q37028786-514B5EC8-ADEC-4667-8164-27275DA65CB7 Q37127107-7CFC75B7-AD63-4A20-A635-84CF0C5B562E Q37220693-72C47245-942F-4355-85B2-8E565AE0F993 Q37296476-B1AB87A0-9227-4406-AA59-BAEA5615B004 Q37529340-937A9A31-A774-48D1-9F81-A21CD5F68CDF Q38209666-7727937C-0CCD-4130-9569-13DCE3C3A2CD Q38297738-A7B2D0D4-F57A-49C8-91CA-19EDF3C90D40 Q38772737-CDAFD7BF-EBAA-469B-BFAA-19DD5DBBAB8C Q39180598-077B38D8-AA67-4192-BDF0-EFCBEAC2BE16 Q39341139-6B6EB519-AD20-47A2-A3C4-A6ADB97EA467 Q39379029-F718EE26-C72A-4329-900B-0791D018F811 Q41094296-750861ED-E2F8-4169-A8AB-420BEFE8CC48 Q41445365-AD71ED00-6F94-492F-B41C-DB1E92A4BB35 Q41487407-A51DECA2-022A-4111-BEE6-B279449293B5 Q41528078-315A68B1-0BE9-4822-B208-31646F767080 Q41872219-8FEEA389-FA4C-405D-A00D-A87BE01DFC13 Q43212779-CC0ADE0D-8F03-4158-81AA-A1C645F71329 Q43678877-995855A9-DDBE-400A-AA07-7A9865A316A2 Q44006284-082B1DE5-F6EF-47B8-98D2-923E7F09649C Q46860543-FCF51162-C197-4D64-9402-D327AE57C826 Q48881089-0C99997C-CF48-4A6C-BC3F-C765D8CDDAB4 Q51373445-07ED987A-3657-431E-AB3F-0C06840EBBD2 Q51391212-75C4A7AD-2048-41D9-B39F-B12D9A48F69E Q57781574-EF02ED7A-165D-4FD3-9FDE-3585FA61FF5D Q58622671-8315A819-CE79-4D82-AC9A-1A833D6C61C2

P2860

Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

http://www.wikidata.org/entity/Q51838864

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.

@en

Predictors of nonalcoholic steatohepatitis

@nl

type

label

Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.

@en

Predictors of nonalcoholic steatohepatitis

@nl

prefLabel

Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.

@en

Predictors of nonalcoholic steatohepatitis

@nl

P1433

Q51838864-C4F4F8C3-1177-4A01-8C9B-E83C9ECBD22F

P1476

Q51838864-056AE37B-1390-4E80-AF89-30F338738FB8

P2093

Q51838864-06C0BCF9-DE0C-49A4-8A54-F4A833E9193D

Q51838864-3E2220C6-C9DB-4FE4-BFCD-393FF9F95D8B

Q51838864-4FD204DD-BE3F-48F1-B1E3-C536B4DFC2B0

Q51838864-576AC357-ED01-4581-96A3-D0D0BFAACA6F

Q51838864-62C4E5C6-280F-4023-B0CE-CCC040564B00

Q51838864-6B9ACDFC-0D4A-4AA5-BF75-148A4E4F1DDE

Q51838864-6E555E79-EA7B-4884-81BF-BB4A357B6023

Q51838864-7C4BC454-9781-4FF3-A059-2B8E45FD4074

Q51838864-914B2767-250A-4970-9870-C39B77D0CB7E

Q51838864-CCE17795-EAFB-4DA6-88C4-D864E8C3302A

P2888

Q51838864-DBB1DA83-308B-48E4-9592-69F2E3BC8DE3

P304

Q51838864-C762E7F7-7CFF-4559-82E3-E8603966355D

P31

Q51838864-6CAF4366-BC00-42A8-8C90-38DEE7783404

P356

Q51838864-D7214D83-B733-42A6-8953-E3CA91C287BF

P433

Q51838864-79F35267-0DC3-4CBC-BB08-381A0E9FA525

P478

Q51838864-A0D813F1-3BD8-499A-ACDA-92DD05F52310

P577

Q51838864-F517D806-619B-47CC-8B7D-48C429ED2156

P6179

Q51838864-CE4C209B-9E17-4F4A-9DAE-DD2722F22057

P698

Q51838864-13147AAA-CDC7-4BE0-B576-3877BA78D58B

P921

Q51838864-3CDB134F-DAA9-4451-87B6-BC663A1781E1

Q51838864-D2B154B9-417E-489C-B0EE-E93BF3C17A43

P356

0960892055002347

P1433

Obesity Surgery

P1476

Predictors of nonalcoholic ste ...... nts undergoing gastric bypass.

@en

P2093

Alejandro Raddatz

http://www.w3.org/2001/XMLSchema#string

Alejandro Soza

http://www.w3.org/2001/XMLSchema#string

Arnoldo Riquelme

http://www.w3.org/2001/XMLSchema#string

Camilo Boza

http://www.w3.org/2001/XMLSchema#string

Enrique Norero

http://www.w3.org/2001/XMLSchema#string

Ignacio Duarte

http://www.w3.org/2001/XMLSchema#string

Jose Ignacio Fernandez

http://www.w3.org/2001/XMLSchema#string

Luis Ibañez

http://www.w3.org/2001/XMLSchema#string

Marco Arrese

http://www.w3.org/2001/XMLSchema#string

Paola Viviani

http://www.w3.org/2001/XMLSchema#string

P2888

0960892055002347

P304

1148-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1381/0960892055002347

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010656165

http://www.w3.org/2001/XMLSchema#string

P698

16197788

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis